|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 2.290 USD | -0.87% |
|
+5.05% | -34.76% |
| 10-08 | Rocket Pharmaceuticals Shares Rise After Goldman Sachs Upgrade | MT |
| 10-08 | Goldman Sachs Upgrades Rocket Pharmaceuticals to Neutral From Sell, Price Target is $4 | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RCKT | Delayed | |
CBOE
| RCKT | Real-time | |
|
Tradegate
| 9IP1 | Real-time | |
|
Deutsche Boerse AG
| 9IP1 | Delayed | |
|
Börse Stuttgart
| 9IP1 | Delayed | |
|
Boerse Muenchen
| 9IP1 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.8 | 3.11 | 3.11 |
| Spread/Res. | -18.21% | -26.37% | -26.37% |
| Spread/Supp. | +5.05% | +5.05% | +5.05% |
| Support | 2.18 | 2.18 | 2.18 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RCKT Stock
- Charts Rocket Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
